A
Price
$125.21
Change
-$0.45 (-0.36%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
35.7B
90 days until earnings call
QGEN
Price
$46.94
Change
+$0.44 (+0.95%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
10.08B
63 days until earnings call
Interact to see
Advertisement

A vs QGEN

Header iconA vs QGEN Comparison
Open Charts A vs QGENBanner chart's image
Agilent Technologies
Price$125.21
Change-$0.45 (-0.36%)
Volume$28.56K
Capitalization35.7B
Qiagen
Price$46.94
Change+$0.44 (+0.95%)
Volume$24.01K
Capitalization10.08B
A vs QGEN Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. QGEN commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongBuy and QGEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (A: $125.66 vs. QGEN: $46.50)
Brand notoriety: A and QGEN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 110% vs. QGEN: 134%
Market capitalization -- A: $35.7B vs. QGEN: $10.08B
A [@Medical Specialties] is valued at $35.7B. QGEN’s [@Medical Specialties] market capitalization is $10.08B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 0 FA rating(s) are green whileQGEN’s FA Score has 1 green FA rating(s).

  • A’s FA Score: 0 green, 5 red.
  • QGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, A is a better buy in the long-term than QGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while QGEN’s TA Score has 5 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 3 bearish.
  • QGEN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, A is a better buy in the short-term than QGEN.

Price Growth

A (@Medical Specialties) experienced а +3.31% price change this week, while QGEN (@Medical Specialties) price change was -6.51% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.10%. For the same industry, the average monthly price growth was +9.54%, and the average quarterly price growth was +9.36%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

QGEN is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Specialties (+0.10% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($35.7B) has a higher market cap than QGEN($10.1B). A has higher P/E ratio than QGEN: A (29.36) vs QGEN (27.51). QGEN YTD gains are higher at: 7.998 vs. A (-6.065). A has higher annual earnings (EBITDA): 1.76B vs. QGEN (715M). A has more cash in the bank: 1.49B vs. QGEN (954M). QGEN has less debt than A: QGEN (1.44B) vs A (3.5B). A has higher revenues than QGEN: A (6.63B) vs QGEN (2.04B).
AQGENA / QGEN
Capitalization35.7B10.1B353%
EBITDA1.76B715M246%
Gain YTD-6.0657.998-76%
P/E Ratio29.3627.51107%
Revenue6.63B2.04B325%
Total Cash1.49B954M156%
Total Debt3.5B1.44B242%
FUNDAMENTALS RATINGS
A vs QGEN: Fundamental Ratings
A
QGEN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
32
Undervalued
PROFIT vs RISK RATING
1..100
6991
SMR RATING
1..100
4768
PRICE GROWTH RATING
1..100
5356
P/E GROWTH RATING
1..100
50100
SEASONALITY SCORE
1..100
285

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QGEN's Valuation (32) in the Medical Specialties industry is in the same range as A (50) in the Biotechnology industry. This means that QGEN’s stock grew similarly to A’s over the last 12 months.

A's Profit vs Risk Rating (69) in the Biotechnology industry is in the same range as QGEN (91) in the Medical Specialties industry. This means that A’s stock grew similarly to QGEN’s over the last 12 months.

A's SMR Rating (47) in the Biotechnology industry is in the same range as QGEN (68) in the Medical Specialties industry. This means that A’s stock grew similarly to QGEN’s over the last 12 months.

A's Price Growth Rating (53) in the Biotechnology industry is in the same range as QGEN (56) in the Medical Specialties industry. This means that A’s stock grew similarly to QGEN’s over the last 12 months.

A's P/E Growth Rating (50) in the Biotechnology industry is somewhat better than the same rating for QGEN (100) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than QGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AQGEN
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
58%
Bullish Trend 5 days ago
56%
Momentum
ODDS (%)
Bullish Trend 5 days ago
64%
Bearish Trend 5 days ago
56%
MACD
ODDS (%)
Bullish Trend 5 days ago
61%
Bearish Trend 5 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
64%
Bearish Trend 5 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
60%
Bearish Trend 5 days ago
53%
Advances
ODDS (%)
Bullish Trend 5 days ago
62%
Bullish Trend 14 days ago
58%
Declines
ODDS (%)
Bearish Trend 8 days ago
60%
Bearish Trend 6 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
56%
Bullish Trend 5 days ago
48%
Aroon
ODDS (%)
N/A
Bullish Trend 5 days ago
45%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KWEB38.180.65
+1.73%
KraneShares CSI China Internet ETF
YYY11.790.01
+0.08%
Amplify High Income ETF
BWG8.62N/A
N/A
BrandywineGLOBAL Global Income Opportunities Fund
WBIF30.10N/A
N/A
WBI BullBear Value 3000 ETF
ILOW41.83-0.09
-0.21%
AB Active ETFs Inc.

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with MTD. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
+0.56%
MTD - A
85%
Closely correlated
+1.40%
WAT - A
79%
Closely correlated
+1.39%
TMO - A
79%
Closely correlated
+0.61%
RVTY - A
78%
Closely correlated
+0.99%
DHR - A
75%
Closely correlated
+0.26%
More

QGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QGEN has been loosely correlated with DHR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if QGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QGEN
1D Price
Change %
QGEN100%
+0.78%
DHR - QGEN
66%
Loosely correlated
+0.26%
RVTY - QGEN
64%
Loosely correlated
+0.99%
BRKR - QGEN
59%
Loosely correlated
+1.55%
TMO - QGEN
59%
Loosely correlated
+0.61%
A - QGEN
59%
Loosely correlated
+0.56%
More